- Home
- / EuBiologics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
EuBiologics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩15.5 K
2024-10-29
Market Capitalization
₩541.1 B
2024-10-29
Revenue
₩149.2 B
FY, 2025
CreditSafe Score
?
Score changed on Jul 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 24.9B | 33.1B | 28.5B | 39.4B | 55.5B | 69.4B | 96.0B | 149.2B |
| Cost of goods sold | 7.6B | 5.2B | 6.3B | 7.6B | 9.3B | 27.0B | 30.6B | 53.8B |
| Gross profit | 18.1B | 27.9B | 25.3B | 31.8B | 46.1B | 42.4B | 65.7B | 95.4B |
| Gross profit margin, % | 72.6% | 84.3% | 88.7% | 80.7% | 83.2% | 61.1% | 68.5% | 63.9% |
| Operating expense total | 10.0B | 15.1B | 22.2B | 32.4B | 42.0B | 25.5B | 21.0B | 24.7B |
| Depreciation and amortization | 2.0B | 3.0B | 5.9B | 7.3B | 8.7B | 31.1B | 18.6B | 13.3B |
| EBITDA | 8.0B | 12.8B | 3.0B | (774.9M) | 3.8B | 16.4B | 44.4B | 70.6B |
| EBITDA margin, % | 32.3% | 38.7% | 10.7% | -2.0% | 6.8% | 23.6% | 46.3% | 47.3% |
| EBIT | 966.5M | 9.6B | (3.3B) | (8.4B) | (5.3B) | (15.3B) | 25.2B | 56.1B |
| EBIT margin, % | 3.9% | 29.1% | -11.4% | -21.4% | -9.6% | -22.1% | 26.2% | 37.6% |
| Interest income | 136.4M | 71.3M | 106.7M | 356.5M | 230.8M | 164.7M | 416.2M | 1.6B |
| Interest expense | 46.1M | 324.9M | 2.1B | 838.1M | 508.3M | 1.1B | 1.1B | 994.4M |
| Pre tax profit | 1.3B | (628.1M) | (60.6B) | (30.8B) | (3.3B) | (14.6B) | 18.5B | 53.8B |
| Income tax expense | (2.5B) | 253.5M | (460.8M) | (2.8B) | 99.2M | 745.0M | (534.5M) | 12.5B |
| Net Income | 3.8B | (881.6M) | (60.1B) | (28.0B) | (3.4B) | (15.4B) | 19.0B | 41.3B |